← Back to Search
Nanodelivery Of Nitazoxanide: Impact On The Metabolism Of Taenia Crassiceps Cysticerci Intracranially Inoculated In Mice.
M. C. Vinaud, D. Real, C. M. Fraga, Nayana F Lima, Ruy De Souza Lino Junior, D. Leonardi, Claudio J Salomon
Published 2020 · Biology, Medicine
Download PDFAnalyze on Scholarcy
Aim: To formulate nanocapsules and nanoemulsions of nitazoxanide (NTZ) and evaluate the metabolic effect on Taenia crassiceps cysticerci inoculated intracranially into mice. Materials & methods: NTZ nanosystems were formulated through solvent diffusion methodology. These nanoformulations were administered perorally and their impact on glycolysis, the tricarboxylic acid cycle and fatty acid metabolism in T. crassiceps cysticerci was investigated. Results: Gluconeogenesis and protein catabolism were significantly increased by the nanoformulations when compared with the control group and the NTZ-treated group. All the other metabolic pathways were inhibited by the nanoformulation treatments. Conclusion: The remarkable metabolic modifications that occur in this in vivo model through the application of these developed nanosystems confirm their capability to deliver NTZ into targeted tissues.
This paper references
Oral nitazoxanide treatment of experimental neurocysticercosis induces gluconeogenesis in Taenia crassiceps cysticerci.
Nayana F. Lima (2019)
Sustained therapeutic efficacy of budesonide‐loaded chitosan swellable microparticles after lung delivery: Influence of in vitro release, treatment interval and dose
Lan Zhang (2018)
In vivo treatment with nitazoxanide induces anaerobic metabolism in experimental intraperitoneal cysticercosis
Joelma M. Nasareth (2017)
Unusual aspects of metabolism in flatworm parasites.
A. G. Tielens (2005)
NANOCARRIERS FOR EFFECTIVE DELIVERY OF BENZNIDAZOLE AND NIFURTIMOX IN THE TREATMENT OF CHAGAS DISEASE: A REVIEW.
E. Arrúa (2019)
Efficacy of nitazoxanide, tizoxanide and tizoxanide/albendazole sulphoxide combination against Taenia crassiceps cysts.
Francisca Palomares-Alonso (2007)
Nanoemulsion: process selection and application in cosmetics – a review
M. N. Yukuyama (2016)
Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: Design, characterization and in vivo pharmacokinetic evaluation.
Sanela M. Đorđević (2015)
Functional ibuprofen-loaded cationic nanoemulsion: development and optimization for dry eye disease treatment.
Bisera Jurišić Dukovski (2019)
Future of nanomedicines for treating respiratory diseases
R. Scherließ (2019)
Chitosan nanoencapsulation of flavonoids enhances their quorum sensing and biofilm formation inhibitory activities against an E.coli Top 10 biosensor.
Eric Omori Omwenga (2018)
Immunoblot with cerebrospinal fluid from patients with neurocysticercosis using antigen from cysticerci of Taenia solium and Taenia crassiceps.
A. Vaz (1997)
Taenia crassiceps: fatty acids oxidation and alternative energy source in in vitro cysticerci exposed to anthelminthic drugs.
M. C. Vinaud (2009)
Taenia crassiceps organic acids detected in cysticerci.
M. C. Vinaud (2007)
Nanopharmaceuticals as a solution to neglected diseases: Is it possible?
G. A. Islan (2017)
Nano-emulsions and Micro-emulsions: Clarifications of the Critical Differences
N. Anton (2010)
Successful treatment of cutaneous leishmaniasis with nitazoxanide.
A. Dhawan (2015)
Praziquantel systems with improved dissolution rate obtained by high pressure homogenization.
M. A. González (2018)
Nitazoxanide: A first-in-class broad-spectrum antiviral agent
J. Rossignol (2014)
Fact or hypothesis: Taenia crassiceps as a model for Taenia solium, and the S3Pvac vaccine
M. Lightowlers (2010)
Taenia solium in Europe: Still endemic?
B. Devleesschauwer (2017)
Simultaneous Spectrophotometric Estimation of Nitazoxanide and Ofloxacin in Tablets
M. D. Game (2011)
Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
A. Hafner (2009)
Recent advancements in brain tumor targeting using magnetic nanoparticles.
Himanshu Gandhi (2020)
Evaluation of nitazoxanide as a novel drug for the treatment of acute and chronic toxoplasmosis.
S. El-Kowrany (2019)
Nano-facilitated drug delivery strategies in the treatment of plasmodium infection.
Nethravathi Puttappa (2019)
Ivermectin: From theory to clinical application.
D. Ashour (2019)
Overview of Taenia solium cysticercosis in West Africa.
R. Weka (2019)
Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction.
F. Sonvico (2006)
Taenia crassiceps: host treatment alters glycolisis and tricarboxilic acid cycle in cysticerci.
Carolina Miguel Fraga (2012)
Cocrystals and alloys of nitazoxanide: enhanced pharmacokinetics.
K. Suresh (2016)
Nitazoxanide Inhibits Human Norovirus Replication and Synergizes with Ribavirin by Activation of Cellular Antiviral Response
W. Dang (2018)
Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine.
Hasan Ali (2016)
DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles
Y. Zhang (2010)
Drug Development Against the Major Diarrhea-Causing Parasites of the Small Intestine, Cryptosporidium and Giardia
Y. Miyamoto (2015)
Development of positively charged colloidal drug carriers: Chitosan-coated polyester nanocapsules and submicron-emulsions
P. Calvo (1997)
Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases.
V. Ceña (2018)
Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methods.
N. Yuksel (2000)
Nitazoxanide: a new broad spectrum antiparasitic agent.
C. White (2004)
Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution
H. H. García (2017)
Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus
J. Rossignol (2016)
Of pigs and people—WHO prepares to battle cysticercosis
J. Maurice (2014)
Treatment of intestinal parasitic infections: a review of nitazoxanide.
H. Gilles (2002)
Polymeric nanoparticles as carrier for targeted and controlled delivery of anticancer agents.
Vahid Taghipour-Sabzevar (2019)
High efficacy of albendazole-PEG 6000 in the treatment of Toxocara canis larva migrans infection.
D. Leonardi (2009)
Conference Scene: From innovative polymers to advanced nanomedicine: Key challenges, recent progress and future perspectives
J. Feijen (2013)
Current Consensus Guidelines for Treatment of Neurocysticercosis
H. García (2002)
Successful treatment of niclosamide- and praziquantel-resistant beef tapeworm infection with nitazoxanide.
Mohammad Lateef (2008)
Nitazoxanide: an important advance in anti-parasitic therapy.
A. White (2003)
Experimental encephalitis caused by Taenia crassiceps cysticerci in mice.
Hidelberto Matos-Silva (2012)
Nitazoxanide: a review of its use in the treatment of gastrointestinal infections.
V. Anderson (2007)
Lipid-Core Nanocapsules Act as a Drug Shuttle Through the Blood Brain Barrier and Reduce Glioblastoma After Intravenous or Oral Administration.
S. F. Rodrigues (2016)
Finding key nanoprecipitation variables for achieving uniform polymeric nanoparticles using neurofuzzy logic technology
Miguel O. Jara (2017)
Nanocapsules for Drug Delivery: An Updated Review of the Last Decade.
Nazlı Erdoğar (2018)
Nanocapsules prepared from amorphous polyesters: effect on the physicochemical characteristics, drug release, and photostability.
M. Fontana (2010)
Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability
A. Neves (2013)
Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations
D. Real (2018)
Nanocapsulation of Nitazoxanide in Solid Lipid Nanoparticles as a New Drug Delivery System and in vitro Release Study
Roghayeh Abbasalipo (2016)
Towards novel antifilarial drugs: challenges and recent developments.
P. Singh (2010)
Resveratrol-Loaded Lipid Nanocarriers: Correlation between In Vitro Occlusion Factor and In Vivo Skin Hydrating Effect
L. Montenegro (2017)
Development and characterization of benznidazole nano- and microparticles: A new tool for pediatric treatment of Chagas disease?
Katia P. Seremeta (2019)